Home>
Stocks>
Beta Drugs Share Price

Beta Drugs Stock Performance

as on January 2, 2026 at 4:01 pm IST

Day's Low
Day's High
₹1,542.9
Day's Price Range
₹1,639.9
₹1,629.4
5.31%
Downside
0.64%
Upside
52 Week's Low
52 Week's High
₹1,429.52
52-Week Price Range
₹2,000
₹1,629.4
12.27%
Downside
22.74%
Upside

Beta Drugs share price movements today

Previous Close: ₹1,545.40
Open: ₹1,560.10
Volume: 5,944.00
Upper Circuit: ₹1,854.40
Lower Circuit: ₹1,236.40
Day's Low - High: ₹1,542.9 - ₹1,639.9
52 Week Low - High: ₹1,429.52 - ₹2,000

Beta Drugs Historical Returns

1 Month Return: -3.62 %
3 Month Return: -10.96 %
1 Year Return: -16.74 %
3 Year Return: + 149.76 %
5 Year Return: + 1337.75 %

Beta Drugs Fundamentals

as on January 2, 2026 at 4:01 pm IST

Market Cap

₹1,644.81 Cr

Return on Equity (ROE)

15.3

PE Ratio (TTM)

Return on capital employed (ROCE)

15.57

Beta (LTM)

1.1

P/B Ratio

14.91

Dividend Yield

PEG Ratio

Quarterly Earnings Growth YOY

EPS (TTM)

42.02

Sector

Pharmaceuticals

Book Value

195.25

Technical Analysis

Bearish

View Technical Analysis

Beta Drugs Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Beta Drugs with its industry peers.

Company	Analyst View	Market Cap(in ₹ Cr)	5 Year CAGR	Debt to Asset Ratio	Net Profit(in ₹ Cr)	Yearly Revenue(in ₹ Cr)
Beta Drugs Ltd	NA	1,644.81	267.55%	0.71	42	362
Blue Jet Healthcare Ltd	BUY	9,212.75	5.69%	0.00	135	498
Vivimed Labs Ltd	NA	125.37	-4%	1.02	-32	116
Piramal Pharma Ltd	BUY	23,724.42	-1.21%	0.69	91	9,151
Sanofi Consumer Healthcare India Ltd	BUY	10,584.41	-1.26%	0.00	181	724

See all

Beta Drugs Share Price Target

Get share price movements and forecasts by analysts on Beta Drugs.

Source: S&P Global Market Intelligence

Beta Drugs Stock’s Investor Sentiment and Interest

Search interest for Beta Drugs Ltd Stock has decreased by -40% in the last 30 days, reflecting a downward trend in search activity.

Time period: December 4, 2025 to January 3, 2026

Change:-40% versus previous 30 day period

Beta Drugs Ltd Annual Profit & Loss

Figures in Rupees Crores

	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Sales	65.93	90.81	116.12	183.84	227.11	295.71	362.36
Other Income	0.37	0.41	0.5	0.76	0.75	1.36	6.44
Total Income	66.3	91.22	116.62	184.59	227.87	297.07	368.79
Expenses	54.12	72.9	91.38	141.14	173.99	235.72	292.32
Operating Profit	11.81	17.91	24.74	42.7	53.12	59.99	70.04
Operating Profit Margin %	17.91%	19.72%	21.31%	23.23%	23.39%	20.29%	19.33%
Profit Before Interest, Tax and Depreciation	12.18	18.32	25.24	43.45	53.88	61.36	76.47
Interest	1.43	2.59	2.42	1.9	2.41	2.82	6.99
Depreciation	2.84	3.76	6.87	7.25	10.41	9.78	12.51
Profit Before Tax	7.91	11.97	15.95	34.3	41.06	48.76	56.97
Tax Paid	-0.13	2.56	4.23	9.48	10.34	12.32	14.55
Profit After Tax	8.04	9.42	11.72	24.83	30.72	36.44	42.42
Total Net profit including share of profit / Loss from associate company	8.04	9.42	11.72	24.83	30.72	36.44	42.42
EPS	9.3	9.93	12.2	25.82	31.95	37.9	42.02
Actual EPS	9.3	9.93	12.2	25.82	31.95	37.9	42.02
Adjusted EPS	8.86	9.46	11.62	24.59	30.43	36.1	42.02
Diluted EPS	9.3	9.93	12.2	25.82	31.95	37.9	42.02

Beta Drugs Ltd Cash Flow

Figures in Rupees Crores

	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Net Cash from Operating Activities	17.1	0.11	8.41	18.6	29.63	23.38	30.93	36.14
Cash Flow from Investing Activities	-10.79	-20.78	-15.06	-5.86	-21.76	-19.07	-13.98	-35.72
Cash Flow from Financing Activities	5.45	12.07	8.72	-7.72	-0.98	-2.47	-7.49	117.97
Net Cash Flow	11.76	-8.61	2.09	5.04	6.9	1.84	9.47	118.39

Beta Drugs Stock Shareholding Pattern

Numbers in percentages

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Nov 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Nov 2025
Promoters	66.73%	66.73%	66.73%	66.73%	66.73%	66.73%	66.73%	66.73%	66.73%	66.73%	66.73%	66.73%	66.73%
DII	0%	0%	0%	0.02%	0%	0%	0%	0%	0%	0%	0%	0%	0%
FII	0%	0%	0%	0.32%	0%	0%	0%	0%	0%	0%	0%	0%	0%
Public	32.94%	32.94%	32.93%	32.92%	32.88%	32.25%	31.95%	31.94%	31.95%	32.2%	32.11%	32.07%	32.08%
Total Outstanding Shares	96,13,790	96,13,790	96,13,790	96,13,790	96,13,790	96,13,790	96,13,790	96,13,860	96,13,860	1,00,94,553	1,00,94,553	1,00,94,553	1,00,94,553
Total Shareholders	1,424	1,451	1,722	1,928	2,116	2,323	2,567	2,793	2,882	3,054	3,139	3,184	3,003

Insights on Beta Drugs Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Retail Holding Up
Retail Investor have increased holdings from 32.07% to 32.08% in Nov 2025 quarter
NO EFFECT
Against Peers
In the last 3 years, Torrent Pharmaceuticals Ltd has given 148.5% return, outperforming this stock by 8.5%
NO EFFECT
Against Peers
In the last 1 year, Torrent Pharmaceuticals Ltd has given 11.8% return, outperforming this stock by 29.2%
NO EFFECT
Promoter Holding Unchanged
Promoters holdings remained unchanged at 66.73% of holdings in Nov 2025 quarter
NEGATIVE IMPACT
FII Holding Down
Foreign Institutions have decreased holdings from 0.91% to 0.87% in Nov 2025 quarter
NEGATIVE IMPACT
Price Dip
In the last 1 month, BETA stock has moved down by -11.4%

About Beta Drugs Ltd

Beta Drugs Limited is a part of the Adley Group, established in 1985 by its promoter Vijay Batra. It is a pharmaceutical formulation manufacturing company that produces and markets drugs to domestic and international customers. The Company specializes in the production of oncology products such as anticancer tablets, capsules, injections and lyophilized injections. With a portfolio of over 50 products catering to various oncology diseases such as breast cancer, brain cancer, bone cancer, lung cancer, mouth cancer, head and neck cancer, prostate cancer, haematology and cervics oeaophagus, Beta Drugs is an important contributor to the healthcare industry. The Company was originally incorporated in Himachal Pradesh in 2005 as a private limited company and was converted into a public limited company in 2017. Under the charge of Vijay Batra, Beta Drugs has become a well-recognized and trusted international healthcare brand.

Listing date: 12 Oct, 2017
Chairperson Name: Rahul Batra

Organisation	Beta Drugs Ltd
Industry	Pharmaceuticals
CEO	Rahul Batra
E-voting on shares	Click here to vote

FAQs

What is Beta Drugs share price today?

Beta Drugs share price today stands at ₹1629.4 as on January 2, 2026 at 4:01 pm IST at the close of the market. Beta Drugs share today touched a day high of ₹1639.9 and a low of ₹1542.9.

What is the 52 week high and 52 week low range for Beta Drugs share?

Beta Drugs touched a 52 week high of ₹2000 and a 52 week low of ₹1429.52. Beta Drugs share price today i.e. January 2, 2026 at 4:01 pm IST is closed at ₹1629.4, which is -18.53% down from its 52 week high and 13.98% up from its 52 week low.

What is Beta Drugs's market capitalisation today?

Beta Drugs market capitalisation is ₹1,644.81 Cr as on January 2, 2026 at 4:01 pm IST.

How to buy Beta Drugs shares?

To buy Beta Drugs shares, you need to follow these steps:

Open a Demat account and Trading account on INDmoney
Fund your Trading account
Search for BETA or Beta Drugs Ltd on the INDmoney app to check live prices of the stock
Click on Buy or SIP to place an order to invest in Beta Drugs shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Beta Drugs trading volume today?

Beta Drugs trading volume is 5,944.00 as on January 2, 2026 at 4:01 pm IST. This means that 5,944.00 shares of Beta Drugs were bought and sold on the stock market during today's trading session.